169 related articles for article (PubMed ID: 22932439)
1. Vaccination: A durable design.
Sanderson K
Nature; 2012 Aug; 488(7413):S7. PubMed ID: 22932439
[No Abstract] [Full Text] [Related]
2. Clinical approval: Trials of an anticancer jab.
Clayton J
Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
[No Abstract] [Full Text] [Related]
3. Public health: Prevention comes of age.
Eisenstein M
Nature; 2012 Aug; 488(7413):S11-3. PubMed ID: 22932434
[No Abstract] [Full Text] [Related]
4. Human papillomavirus vaccines: WHO position paper, October 2014.
Wkly Epidemiol Rec; 2014 Oct; 89(43):465-91. PubMed ID: 25346960
[No Abstract] [Full Text] [Related]
5. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
[No Abstract] [Full Text] [Related]
6. Fewer shots proposed to increase uptake of HPV vaccine.
Dorans K
Nat Med; 2010 Aug; 16(8):832-3. PubMed ID: 20689528
[No Abstract] [Full Text] [Related]
7. No Vacillation on HPV Vaccination.
Sipp D; Frazer IH; Rasko JEJ
Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus.
Brody H
Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432
[No Abstract] [Full Text] [Related]
9. HPV vaccination and cervical cancer.
Szarewski A
Curr Oncol Rep; 2012 Dec; 14(6):559-67. PubMed ID: 22890794
[TBL] [Abstract][Full Text] [Related]
10. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
[No Abstract] [Full Text] [Related]
11. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim JJ
PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
[TBL] [Abstract][Full Text] [Related]
12. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
[No Abstract] [Full Text] [Related]
14. Vaccination against human papillomavirus.
Mello CF
Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
[TBL] [Abstract][Full Text] [Related]
15. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
16. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
17. Australian HPV vaccination programme yields results.
Howe M
Lancet Oncol; 2014 Dec; 15(13):e591. PubMed ID: 25499291
[No Abstract] [Full Text] [Related]
18. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
[No Abstract] [Full Text] [Related]
19. For debate: that Australia should continue using the quadrivalent vaccine.
Wain G
Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
[No Abstract] [Full Text] [Related]
20. NIH lab helps get vaccine from bench to bedside.
Traynor K
Am J Health Syst Pharm; 2007 Mar; 64(5):452. PubMed ID: 17322152
[No Abstract] [Full Text] [Related]
[Next] [New Search]